PT Bundamedik Tbk (ISX:BMHS) NonCurrent Deferred Liabilities: Rp0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp188.00
GF Value Rp311.17
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk NonCurrent Deferred Liabilities?

PT Bundamedik Tbk ISX:BMHS -1.05% 61 NonCurrent Deferred Liabilities is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp311.17 (Possible Value Trap). The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

PT Bundamedik Tbk's non-current deferred liabilities for the quarter that ended in Mar. 2026 was Rp0 Mil.

PT Bundamedik Tbk NonCurrent Deferred Liabilities Related Terms

PT Bundamedik Tbk NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk NonCurrent Deferred Liabilities Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of Rp0 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a NonCurrent Deferred Liabilities of Rp0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's NonCurrent Deferred Liabilities too high?
PT Bundamedik Tbk's current NonCurrent Deferred Liabilities is Rp0 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's NonCurrent Deferred Liabilities compare to HCA and THC?
PT Bundamedik Tbk's NonCurrent Deferred Liabilities of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current NonCurrent Deferred Liabilities is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp311.17, compared to a current price of Rp188.00 — trading 39.6% below its estimated fair value. The current NonCurrent Deferred Liabilities is Rp0 Mil. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current NonCurrent Deferred Liabilities is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp188.00 is trading 39.6% below its estimated GF Value™ of Rp311.17. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • NonCurrent Deferred Liabilities: Rp0 Mil
  • GF Value™: Rp311.17 vs. price of Rp188.00 (39.6% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp188.00
Price
Rp311.17
GF Value